Cargando…
Effect of Deamino-8-D-Arginine Desmopressin in Uremic Bleeding
OBJECTIVES: This study is designed to evaluate the clinical outcome of uremic bleeding treated with DDAVP. DDAVP was given intravenously in nine ESRD patients who had undergone A/V fistula surgery and showed oozing of the operation site for more than one hour. METHODS: Hemostasis was observed by rem...
Autores principales: | Hong, Sae-Yong, Yang, Dong-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532022/ https://www.ncbi.nlm.nih.gov/pubmed/8854651 http://dx.doi.org/10.3904/kjim.1996.11.2.145 |
Ejemplares similares
-
Improved radiotracing of oxytocin receptor-expressing tumours using the new [(111)In]-DOTA-Lys(8)-deamino-vasotocin analogue
por: Chini, B, et al.
Publicado: (2003) -
Safety of renal biopsy bleeding prophylaxis with desmopressin
por: Barrios, R. Haridian Sosa, et al.
Publicado: (2021) -
Desmopressin and bleeding risk after percutaneous kidney biopsy
por: Athavale, Ambarish, et al.
Publicado: (2019) -
Effect of Desmopressin on Bleeding After Heart Surgeries: A Narrative Review
por: Jahangirifard, Alireza, et al.
Publicado: (2023) -
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients
por: Weinberg, Ruth S, et al.
Publicado: (2015)